Copyright
©2012 Baishideng.
World J Obstet Gynecol. Oct 10, 2012; 1(3): 20-28
Published online Oct 10, 2012. doi: 10.5317/wjog.v1.i3.20
Published online Oct 10, 2012. doi: 10.5317/wjog.v1.i3.20
Gene | Gene mutation/expression | Phneotypic effects/complications |
CDK19 | Chromosome breakpoints in 6p12.1 and 6q21 | Microcephaly, congenital bilateral falciform retinal folds, nystagmus, and mental retardation[9] |
NFIA | Chromosome 1p32-p31 deletion syndrome | Ventriculomegaly, corpus callosum hypogenesis, abnormal external genitalia, and intrauterine growth restriction in the third trimester[44] |
IGF1R | Novel c.420del mutation in exon 2 of the IGF1R gene | Reduced IGF1R expression and represents haploinsufficiency of the IGF1R gene. IUGR and neonatal growth retardation[10] |
hPGH, IGF-I, IGFBP-1 | Decreased expression | Decreased expression is associated with IUGR[27] |
c-fos | Decreased expression | Fetal alcohol syndrome[45] |
11b-HSD2 | Glucocorticoid metabolism | Under expression cause IUGR, small placenta[55] |
GSTP1 | Glutathione transferase enzymes pathway | Fetal growth and neonatal growth[56] |
ZMPSTE24 | Fetal growth | IUGR, dermopathy, neonatal death[43] |
Ascl2 | Placenta development | Three layers malformation, IUGR[44] |
TFRC | Transferrin receptor function | IUGR[13] |
DIO3 | Type 3 deiodinase | Highly expressed in placenta and fetus. IUGR and hypothyroidism[47] |
DLK1 | Growth promoter | Expressed in placental villi. Methylation defects associated with IUGR[16] |
HYMAI | Non-coding RNA | Transient neonatal diabetes and IUGR[57] |
IGF2 | Growth Factor | Placental and fetal growth restriction[58] |
KCNQ1OT1 | Non-coding RNA | Control placental Kcnq1 domain. Involved in Beckwith-Wiedemann syndrome[59] |
MAGEL2/NDNL1 | Similarity to NDN | Neonatal growth retardation, alter metabolism[60] |
MEST | Neuronal differentiation | Fetal growth restriction, smaller placentas[52] |
PEG10 | Retrotransposon-derivedgene | Severe growth retardation, absence of spongiotrophoblast layer, embryonic lethality[61] |
PEG3 | Inhibits WNT-signalling | Placental and fetal growth restriction and abnormal maternal behavior[62] |
PLAGL1 Zac1 | Tumor suppressor | Skeletal defects, neonatal lethality, IUGR, and disrupted transactivation of Igf2[63] |
SFRP2 | WNT signaling | Reduction in vitro of extra villous trophoblast invasion[64] |
HBII-85/PWScr | C/D Box small RNA | Implicated in Prader Willi, Postnatal growth retardation[65] |
- Citation: Zhang XQ. Intrauterine growth restriction and genetic determinants - existing findings, problems, and further direction. World J Obstet Gynecol 2012; 1(3): 20-28
- URL: https://www.wjgnet.com/2218-6220/full/v1/i3/20.htm
- DOI: https://dx.doi.org/10.5317/wjog.v1.i3.20